Minerva Medica ^None

Minerva Medica is a regenerative medicine company that focuses on developing and selling products for the treatment of diabetic nephropathy using autologous bone marrow mesenchymal stem cells. The company was founded in 2017 and is based in Hokkaido, Japan. They are conducting research on a treatment method using autologous mesenchymal stem cells in collaboration with Sapporo Medical University. The goal is to establish a stable cell production system and provide healthcare professionals with a safe and effective treatment method for diabetic nephropathy. No information is provided on the company's valuation or funding.